Constant Therapeutics LLC
2 clinical trials · Sponsor
◉ Watch Constant Therapeutics LLC
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of TXA127 in Post-ischemic Stroke Patients (NCT06135103) | Constant Therapeutics LLC | 2023-11-26 |
| TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy (NCT06013839) | Constant Therapeutics LLC | 2023-08-31 |
Track Constant Therapeutics LLC automatically
Every clearance here is in the API, with alerts when new ones post.